Genome British Columbia

Genome BC, a non-profit research organization, leads genomics innovation on Canada’s West Coast and facilitates the integration of genomics into society. Their major investors are the Province of British Columbia and the Government of Canada through Genome Canada and Western Economic Diversification Canada. This funding is complemented by partnerships with many national and international public and private funding organizations to drive BC’s bioeconomy.

Tony Brooks

CFO and VP Entrepreneurship and Commercialization

12 past transactions

LightIntegra Technology Inc.

Venture Round in 2020
LightIntegra Technology is a privately funded medical diagnostics company and launched from the Canadian Blood Services R&D labs through the efforts of research scientist Dr. Elisabeth Maurer. LightIntegra strives to minimize platelet refractoriness. To this end, LightIntegra created ThromboLUX, a rapid in-vitro test that provides size distribution information for microparticles in blood products. As a routine test for platelet concentrates, ThromboLUX may identify which platelet units would be best suited for prophylaxis and which units are better suited for therapeutic use. Her years of research on platelet function led to a breakthrough discovery using dynamic light scattering to characterize platelets. Dr. Maurer recognized the opportunity to use this breakthrough - coupled with advances in laser and optics technology – to address a market need to provide a safe, quick and simple diagnostic test for microparticles, platelet quality and function.

Sonic Incytes

Seed Round in 2020
Sonic Incytes is a medical device start-up company developing quantitative ultrasound for point-of-care diagnostic and procedure guidance. our mission to enable routine assessment and management of liver health, with diagnostic accuracy you can count on.

BarrelWise Technologies

Seed Round in 2020
BarrelWise Technologies creates technology to improve wine production and analysis, with products used by wineries in British Columbia, California, and Washington. The FS1 System, the company's flagship product, enables wineries to bring routine free SO2 checks to the cellar, reducing the process from days to minutes while maintaining lab-level accuracy.

Acuva Technologies

Series B in 2019
Acuva Technologies is developing ultraviolet light emitting diode (UV-LED) based drinking water purification systems targeting low to moderate volumes of water in various sizes. Acuva’s reactor is a compact, modular, and scalable system comprising UV LEDs, to provide a dose of UV radiation to water flowing through the device. The UV puriication system obtains germicidal destruction of biological contaminants such as viruses and bacteria.

Alavida

Venture Round in 2019
Alavida offers the Scientific Solution for Alcohol Addiction.

Starling Minds

Seed Round in 2019
Starling Minds provides Online Cognitive Behavioral Therapy Program, Mental Health, Workplace Productivity, Stress Management, Workplace Mental Health, Digital Mental Health Solutions, Digital CBT, and Digital Cognitive Behavioral Therapy.
LightIntegra Technology is a privately funded medical diagnostics company and launched from the Canadian Blood Services R&D labs through the efforts of research scientist Dr. Elisabeth Maurer. LightIntegra strives to minimize platelet refractoriness. To this end, LightIntegra created ThromboLUX, a rapid in-vitro test that provides size distribution information for microparticles in blood products. As a routine test for platelet concentrates, ThromboLUX may identify which platelet units would be best suited for prophylaxis and which units are better suited for therapeutic use. Her years of research on platelet function led to a breakthrough discovery using dynamic light scattering to characterize platelets. Dr. Maurer recognized the opportunity to use this breakthrough - coupled with advances in laser and optics technology – to address a market need to provide a safe, quick and simple diagnostic test for microparticles, platelet quality and function.

Aspect Biosystems

Venture Round in 2018
Aspect Biosystems is a biotechnology company developing bioprinted tissue therapeutics to transform how we treat disease. By combining its proprietary microfluidic 3D bioprinting technology, therapeutic cells, and materials science, Aspect is creating a pipeline of allogeneic cell-based tissue therapeutics to replace or repair damaged organ functions. The company is also partnering with leading researchers and industry innovators worldwide to tackle the biggest challenges in regenerative medicine.

Microbiome Insights Inc.

Venture Round in 2017
Microbiome Insights, Inc. is a global leader providing end-to-end services for microbiome DNA sequencing, including state-of-the-art bioinformatic analysis. Based in Vancouver, Canada, the company's customized suite of services enables researchers and clinicians to easily and effectively include microbiome analysis in studies across a range of human, animal, agricultural and environmental applications. The multidisciplinary team of researchers and knowledge leaders at the company's helm provide access to decades of expertise in traditional sciences such as ecology, microbiology, infectious diseases, and genetics. Microbiome Insights' award-winning team is committed to providing clients with fast, dependable, cost-effective results.

CuePath Innovation

Seed Round in 2017
CuePath Innovation is a health tech company. They design medication packaging for seniors and provide a service that enables families to ensure that their senior family members stay on track with medications through mobile devices. They develop medication compliance monitoring products for clinical trials that dispense doses of tablets or capsules in blister packaging.

Anandia

Venture Round in 2016
Anandia Laboratories Inc. is a biotechnology company based in Vancouver, Canada, that specializes in the testing and development of cannabinoid products. Founded in 2014, Anandia focuses on providing analytical testing services, including assessments of potency, pesticides, microbes, and terpenes, primarily to licensed cannabis producers and patients. The company leverages its scientific expertise in cannabis genomics and modern plant breeding techniques to support customers in interpreting testing results and addressing any identified issues. As of August 2018, Anandia operates as a subsidiary of Aurora Cannabis Inc., enhancing its capabilities in the rapidly evolving cannabis industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.